APT001

N/A

Report date: 2024/12/09 20:01:07

Base Information

Drug NameAPT001
Drug Alias NameAPT001APT-001
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsBlepharitisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkGuatemala
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAptol Pharma APS
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBlepharitisArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A